De Cosio, Ana Paola
Thornton, Paul
Article History
First Online: 20 June 2019
Compliance with Ethical Standards
:
: Funding for the preparation of this manuscript was provided in part by the Cook Children’s Health Care System Endowed Chair program.
: Paul Thornton has received consulting fees from Xeris Pharmaceuticals (the maker of stable liquid glucagon) and is a PI for both Xeris and Zealand in studies involving an investigational new drug for the treatment of congenital hyperinsulinism. Ana P. De Cosio has no conflict of interest to declare.